HMF Multi Strain 50 30 Veggie Caps

15-strain probiotic combination*
• Helps to reduce intestinal transit time*
• Helps support a healthy immune system*
• May enhance aspects of cellular immunity*
• Supports gastrointestinal health*
• Supports a favorable gut flora*

HMF^® Multi Strain 50 capsules include 50 billion CFU from a combination of 15 probiotic strains. These research-driven strains were selected based on their ability to support both gastrointestinal and immune health. HMF Multi Strain 50’s probiotic consortium contains proprietary human-sourced strains, and includes 8 strains of Lactobacilli and 6 strains of Bifidobacteria. Saccharomyces cerevisiae subsp. boulardii (CNCM-I-1079) live yeast cells are also provided for additional microflora support.
In a recent placebo-controlled clinical trial, daily supplementation with HN019 for two weeks significantly reduced intestinal transit time; following supplementation, intestinal transit time was decreased by approximately 30%, which was associated with an approximate 35.8% reduction in occasional constipation. BL-04 and NCFM™ support year-round immune health and may enhance certain aspects of cellular immunity, such as cytokine-dependent cellular signaling.  Two recent, placebo-controlled human clinical trials have found that these strains provide support for seasonal immune health in healthy participants. As well, supplementation with a combination of CUL-60, CUL-21, CUL-31 and CUL-20 may help to enhance certain aspects of cellular immunity in healthy individuals.*

EACH CAPSULE CONTAINS: Probiotic Consortium. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50 Billion CFU Lactobacillus acidophilus (CUL-60). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10 Billion CFU Lactobacillus acidophilus (CUL-21). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10 Billion CFU Bifidobacterium animalis subsp. lactis (CUL-34). . . . . . . . . . . . . . . . . . 4.75 Billion CFU Bifidobacterium bifidum (CUL-20). . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.25 Billion CFU Bifidobacterium animalis subsp. lactis (HN019). . . . . . . . . . . . . . . . . . . . . 5 Billion CFU Bifidobacterium animalis subsp. lactis (BL-04). . . . . . . . . . . . . . . . . . . 3.75 Billion CFU Lactobacillus salivarius (CUL-61). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Billion CFU Lactobacillus paracasei (CUL-08). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Billion CFU Lactobacillus casei (CUL-06). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Billion CFU Lactobacillus gasseri (CUL-09). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Billion CFU Bifidobacterium breve (CUL-74). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Billion CFU Lactobacillus plantarum (CUL-66). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Billion CFU Lactobacillus acidophilus (NCFM®). . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.25 Billion CFU Bifidobacterium animalis subsp. lactis (CUL-62). . . . . . . . . . . . . . . . . . . 1.5 Billion CFU Saccharomyces cerevisiae subsp. boulardii (CNCM-I-1079). . . . . . . . . . 0.5 Billion CFU Non-Medicinal Ingredients: Cellulose, hypromellose, silica

Recommended Dose: Adults, Adolescents and Children (6 years and older): Take one capsule daily, at least two to three hours before or after taking antibiotics and/or antifungals, or as recommended by your healthcare practitioner.

Risk Information: If you have an immune-compromised condition, do not use. If you are experiencing fever, vomiting, bloody diarrhoea or severe abdominal pain, consult your healthcare practitioner prior to use. If symptoms of digestive upset occur, worsen, or persist beyond three days, discontinue use and consult your healthcare practitioner